======= TAF1C =======
== Gene Information ==
* **Official Symbol**: TAF1C
* **Official Name**: TATA-box binding protein associated factor, RNA polymerase I subunit C
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9013|9013]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q15572|Q15572]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TAF1C&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF1C|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604905|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (preinitiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits. Recruits RNA polymerase I to the rRNA gene promoter via interaction with RRN3. {ECO:0000269|PubMed:11250903, ECO:0000269|PubMed:15970593}.
No Pfam Domain information is available for this gene.
|RNA polymerase I CORE element sequence-specific DNA binding|
|RNA polymerase I preinitiation complex assembly|
|transcription elongation from RNA polymerase I promoter|
|transcription preinitiation complex assembly|
|termination of RNA polymerase I transcription|
|regulation of transcription by RNA polymerase I|
|transcription initiation from RNA polymerase I promoter|
|transcription by RNA polymerase I|
|positive regulation of gene expression, epigenetic|
|DNA-templated transcription, termination|
|DNA-templated transcription, elongation|
|fibrillar center|
|protein-DNA complex assembly|
|DNA-templated transcription, initiation|
|regulation of gene expression, epigenetic|
|protein-DNA complex subunit organization|
|transcription by RNA polymerase II|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|cellular protein-containing complex assembly|
|nucleolus|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|protein-containing complex assembly|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|protein-containing complex subunit organization|
|positive regulation of gene expression|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-1.98|
|[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|-1.97|
|[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-1.85|
|[[:results:exp130|JQ1 0.01μM R03 exp130]]|-1.79|
|[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-1.76|
|[[:results:exp121|Golgicide-A 2μM R03 exp121]]|-1.71|
^Gene^Correlation^
|[[:human genes:h:hars|HARS]]|0.497|
Global Fraction of Cell Lines Where Essential: 706/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|28/28|
|bone|25/25|
|breast|31/33|
|central nervous system|56/56|
|cervix|4/4|
|colorectal|17/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|13/15|
|kidney|21/21|
|liver|18/20|
|lung|75/75|
|lymphocyte|14/14|
|ovary|24/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|7/7|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|27/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 965
* **Expression level (log2 read counts)**: 6.45
{{:chemogenomics:nalm6 dist.png?nolink |}}